JELD-WEN Holding is rated a 'Sell' due to declining fundamentals, high leverage with a net debt of $1.19 billion, and ongoing revenue drops, especially in North America. Despite management's hopes for better profitability and cash flow, the company's net leverage ratio of 8.78 and recent debt refinancing that extends maturities to 2031 highlight its distressed financial state. Upcoming Q3 2026 results may show slight EPS improvement but continued revenue decline suggests investors should remain cautious.
JELD-WEN Holding's net debt of $1.19 billion highlights its financial challenges. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 30, 2026 22:41 WIB: out of 134 priced US stocks, 37 rose and 95 fell. Notable movers include LCID at USD 3.02 with a -5.78% change and 100% buy order activity, TDUP at USD 2.11 down 4.95%, and VSXY at USD 94.40 down 4.78% with 100% buy order activity and typical hold times ranging from 30 to 46 days.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
